Objective To investigate the relationship between myocardial injury and damage of me-chanical synchrony in the left ventricle of patients with ischemic cardiomyopathy ( ICM) using 99 Tcm-MIBI MPI and gated 18 F-FDG myocardial metabolic PET imaging. Methods A total of 113 ICM patients ( 100 males, 13 females;average age (58±10) years) underwent 99Tcm-MIBI MPI and gated 18F-FDG myocardial metabolic PET imaging from July 2015 to December 2015 in Fu Wai Hospital were retrospectively analyzed. Three-point scoring system was used for quantitative assessment of myocardial ischemia and myocardial in-farction in each segment. Total ischemic score ( TIS) and total scar score ( TSS) of 17 segments were calcu-lated in each patient. The phase bandwidth ( BW) and phase SD were derived from phase analysis. Pearson correlation analysis and logistic regression analysis were used. Results TSS were correlated with BW and SD in all 93 patients with myocardial infarction ( r values:0. 517, 0.470, both P<0.01) and also in a sub-group of 34 patients with myocardial infarction and without myocardial ischemia ( r values: 0. 647, 0. 578, both P<0.01) . There were significant correlations between TIS and BW, SD in 79 patients with myocardial is-chemia ( r values:0.392, 0.378, both P<0.01) , but no significant correlation was found in a subgroup of 20 patients with myocardial ischemia and without myocardial infarction ( r values: 0. 002, -0. 003, both P>0. 05) . Logistic regression analysis showed that the number of myocardial infarction segments and TSS were as-sociated with mechanical dyssynchrony. Conclusion Myocardial infarction is the main factor of left ventricu-lar mechanical dyssynchrony in ICM patients, but chronic myocardial ischemia has no significant influence on mechanical dyssynchrony.

Objective To investigate the prognostic value of interim 18 F-FDG PET/CT scan in pa-tients with natural killer ( NK)/T cell lymphoma. Methods From January 2012 to May 2015, thirteen pa-tients (10 males, 3 females;mean age (43.85±7.66) years) underwent methotrexate+ifosfamide+etoposide+prednisone acetate+L-asparaginase ( SMILE ) chemotherapy. All patients underwent pre-, mid-treatment ( after 3 cycles of SMILE) PET/CT scan, and 9 of them further underwent end-treatment ( after 6 cycles of SMILE) PET/CT scan.View analysis and ΔSUVmax(%) were used to interpret 18F-FDG PET/CT images. Two-sample t test was used to analyze the difference of ΔSUVmax between PET/CT positive group and PET/CT-negative group. Survival curves were obtained using Kaplan-Meier analysis. OS and PFS were calculated and compared with the log-rank test. Results All 13 patients underwent 18 F-FDG PET/CT imaging after 3 chemotherapy cycles and were divided into PET/CT-negative group (7 patients) and positive group (6 pa-tients). ΔSUVmax of the negative group was higher than that of the positive group: (65.73±5. 95)% vs (52. 50±1.49)%;t=4.199, P<0.05. Median follow-up period was 26 (9-48) months. The median PFS and median OS of PET/CT-negative group were higher than those of PET/CT-positive group ( 39 vs 18 months, 44 vs 24 months; χ2=4.521, 4.829, both P<0.05). Conclusion Interim PET/CT scan could predict the outcome of patients with NK/T cell lymphoma.

Objective To investigate the prognostic value of SUVmax , SUVmean , MTV and TLG cal-culated from 18 F-FDG PET/CT in patients with postoperative esophageal cancer. Methods Sixty-one pa-tients ( 51 males, 10 females;age ranged 50-81 ( median:64) years) with esophageal cancer who under-went preoperative 18 F-FDG PET/CT from October 2007 to November 2015 were retrospectively analyzed. The relation of SUVmax , SUVmean , MTV and TLG in primary lesions with clinic pathological factors was ana-lyzed. Differences of metabolic parameters were compared with two-sample t test, one-way analysis of vari-ance, Mann-Whitney u test or Kruskal-Wallis H test. The optimal cutoff points of SUVmax , SUVmean , MTV and TLG for predicting overall survival ( OS) were investigated by ROC curve analysis. The Kaplan-Meier method and log-rank test were used to perform univariate survival analysis, and Cox proportional hazards model was used for multivariate analysis. Results MTV and TLG were associated with tumor length, N stage and clinical stage, while SUVmax and SUVmean were only associated with tumor length ( t=-2.396, F=4.206, 4. 471;z=-3.051,χ2=8.908, 9.796;t=-2.417,-2.423;all P<0. 05) . The optimal cutoff points of SUVmax, SUVmean, MTV and TLG were 11.76, 7.06, 24.35 cm3 and 166. 84 g, respectively. Univariate analysis of OS showed that the lymphatic metastasis, clinical stage and TLG were all significantly associated with the patient outcome (χ2=14.683, 7.139, 11.669, all P<0.05) . Multivariate analysis showed that lym-phatic metastasis and TLG were the independent predictors for OS (β=-1. 472, -1. 223; Wald=5. 224, 4. 668;both P<0.05) . Conclusion For predicting the prognosis of esophageal cancer after operation, TLG of the primary tumor may be more valuable than SUVmax , SUVmean and MTV.

Objective To evaluate the value of 18 F-FDG PET/CT imaging in predicting the progno-sis of newly diagnosed SCLC with normal serum LDH ( SCLC-nsLDH) . Methods A total of 68 SCLC pa-tients (59 males, 9 females, median age:58.5 years) proved by pathology between June 2005 and Decem-ber 2016 were retrospectively analyzed. All patients underwent 18 F-FDG PET/CT. The general information of patients, including LDH, NSE, OS, PFS and SUVmax , were recorded. SUVmax differences were analyzed with Mann-Whitney u test. Life-table method and Kaplan-Meier analysis were used to estimate the survival rate and median survival time. The survival function curve was drawn. Log-rank test was used to analyze whether there existed statistical differences in survival period among different groups. Cox regression analysis was used for screening the influencing factors of prognosis. Results ( 1) In 68 SCLC patients, there were 38 cases with limited disease ( LD) and 30 cases with extensive disease ( ED) . There were 3 cases in stageⅠ, 7 cases in stage Ⅱ, 29 cases in stage Ⅲ, 29 cases in stage Ⅳ. The median SUVmax of the primary tumor was 11.35 (9.90, 13.90). There was no significant difference between the median SUVmax of LD group and that of ED group:11.05(9.72, 13.60) vs 12.25(10. 05, 14.12)months;z=-0.797, P=0.426. The median serum LDH was 195.15(171.00, 220.80) U/L. (2) The median follow-up time was 18(range:2-101) months. The disease developed in 46 patients and 35 patients died. The median OS was 23 (95%CI:13.3-32.7) months and median PFS was 17 (95% CI: 11.4-22.6) months. (3) ROC curve showed the optimal SUVmax cutoff value was 10.85. The OS of patients with SUVmax≤10.85 ( n=25) and with SUVmax>10.85 (n=43) were 40.0(95% CI:2.5-77.5) months and 18.0(95% CI:13.3-22.7) months(χ2=8.956, P=0.003), respectively. (4)Weight loss, VALG stage and primary tumor SUVmax were independent prog-nostic factors for OS (all P<0.05). Only VALG stage was an independent prognostic factor for PFS (P<0. 001) . Conclusion 18 F-FDG PET/CT can help to differentiate the different prognosis of SCLC-nsLDH patients, and provide more evidence for the choice of individual treatment strategy.

Breast cancer is one of the most common malignant tumors in women, and its morbidity is increasing gradually in recent years. Precision treatment has been developed with individualized and standardized protocols according to the molecular classification of breast cancer. Targeted therapy is one of the most important methods. How to evaluate targeted therapy is the focus of attention. PET/CT plays an im-portant role in the diagnosis, staging, treatment plan and evaluation of therapeutic effect and prognosis, es-pecially in targeted therapy of breast cancer. This review summarizes the applications of PET/CT in targeted therapy of breast cancer.

Recently, either in the field of preoperative differential diagnosis and staging, or in the diagnosis of postoperative recurrence and distant metastasis, the application of PET/CT in pancreatic cancer attracts more and more attention. Combining the precise anatomical information of CT with the functional metabolic information of PET, 18 F-FDG PET/CT can not only accurately locate the T staging, but also de-tect regional or distant metastasis, which make the early diagnosis and staging of pancreatic cancer easier. This review summarizes the recent progress of PET/CT imaging in the clinical application of pancreatic cancer by comparison of the contrast enhanced CT and MRI, trying to analyze different imaging modalities in clinical management of pancreatic cancer.

Objective To investigate the physical and magnetic properties and cytotoxity of 5-FAM-dextran-coated superparamagnetic iron oxide nanoparticles ( 5-FAM-dextran-Fe3 O4 ) , and to observe the cell-labeling character of these nanoparticles. Methods 5-FAM-dextran-Fe3 O4 were prepared by ultra-sonic and chemical coprecipitation method and the characteristics were evaluated. The size and distribution of 5-FAM-dextran-Fe3 O4 were measured by transmission electron microscope ( TEM) and Malvern Zetasizer. The organic structure of the coating was characterized by fourier translation infrared spectroscopy. The optical imaging ability was measured by ultraviolet visible spectrometer and the susceptibility was measured by vi-brating sample magnetometer. In vitro cytotoxities of 5-FAM-dextran-Fe3 O4 , dextran-Fe3 O4 and Fe3 O4 were detected by MTT assay. The area of labeled neuronal cells was observed by confocal microscopy after incuba-ted with nanoparticles under different magnetic intensities. One-way analysis of variance was used. Results The size of 5-FAM-dextran-Fe3 O4 was homogeneous under TEM, and the diameter ranged from 15 to 25 nm ( average=22 nm) by Malvern Zetasizer. The organic structure of the coating of Fe3 O4 was confirmed by fou-rier translation infrared spectroscopy. Ultraviolet visible spectrometer observation showed that the nanoparti-cles expressed unanimous green fluorescence under ultraviolet activation. The saturation magnetization, residu-al magnetization and coercivity of the nanoparticles by magnetometer detection were 86. 02 A · m2 · kg-1 , 15. 05 A·m2 ·kg-1 and 5414.01 A/m respectively, showing superparamagnetic character. MTT assay re-sults showed that 5-FAM-dextran-Fe3 O4 had no obvious cytotoxicity. The confocal microscopy observation in-dicated that the cell-labeled area reached the maximum under the magnetic field intensity of 500 mT ((0. 880±0.146) mm2, F=320.298, P<0.05). Conclusions 5-FAM-dextran-Fe3O4 prepared by ultra-sonic coprecipitation method have the advantages of small size, good homogeneity and magnetic property. Therefore, they might be used as the fluorescent magnetic bio-probe in laboratory and clinical studies.

Objective To synthesize 18 F-DPA-714 and to study its labeling rate, radiochemical purity, stability and biological characteristics. Methods 18F-was reacted with K2CO3/K2.2.2 and then en-gaged in nucleophilic substitution with DPA-714. The crude product was purified by aluminum column and semi-preparation HPLC. The stability of 18 F-DPA-714 was identified in PBS and plasma. The lipid-water partition coefficient (LogP) was determined. Biodistribution analysis and microPET imaging were performed on mice and rats respectively. Results It took about 25 min for synthesizing 18 F-DPA-714, the radiochemi-cal yield was 31.6% (decay not corrected), and the radiochemical purity was ≥99%. The product re-mained stable within 4 h. The LogP of 18 F-DPA-714 was 2.71. Pharmacokinetics of 18 F-DPA-714 was more in line with the two compartment model, with the distribution half-life ( T1/2α) of 2.40 min and the elimina-tion half-life( T1/2β) of 69.15 min. 18 F-DPA-714 was quickly uptaken by tissues after the tail vein injection. It mainly distributed in the lungs, kidneys, and heart, with the radioactive uptake values of (17.85±7.52)%ID/g, (15.41±1.80) %ID/g and (10.56±0.94) %ID/g at 30 min post-injection, respectively. 18F-DPA-714 was mainly metabolized through the liver, and excreted by the kidneys. The uptake in bones was stable. PET dynamic scanning showed that 18 F-DPA-714 accumulated in the brain of aged rats and cleared slowly within 60 min. Conclusions 18 F-DPA-714 prepared in this study has high labeling rate, short synthesis time and small precursor dosage. It displays good biological distribution and blood-brain barrier permeability characteristics.

Objective To investigate the effect of curcumin on brain glucose metabolism in rat models of intracerebral hemorrhage ( ICH), and evaluate the therapeutic effect of curcumin. Methods Twenty-four healthy adult male SD rats were randomly divided into 4 groups ( 6 rats/group) by simple random sampling method:normal group ( group A) , ICH+curcumin group ( group B) , ICH +vehicle group ( group C) , and sham operated group (group D). ICH model was made by injecting collagenase (2 μl) into the right cau-date nucleus of rat. 18F-FDG with a dose of (17.8±0.4) MBq was injected through caudal vein at 6 h, 24 h, 48 h, 3 d, 5 d, 7 d, 14 d after the model was built successfully. 18F-FDG microPET/CT was performed 30 min post injection at each time point. ROI in the hematoma and peri-hematoma brain tissue was drawn, and its volume and SUVmean were measured and analyzed. Meanwhile, each rat was evaluated by neurological severi-ty scores ( NSS) . Analysis of variance for repeated measurement data and Pearson correlation analysis were used. Results NSS in group B were lower than those in group C from 6 h to 5 d (F=183.26, P<0. 01). MicroPET/CT showed decreased glucose uptake in the hematoma and peri-hematoma brain tissue after cere-bral hemorrhage. In group B, the 18 F-FDG uptake in peri-hematoma brain tissue of ICH decreased after 6 h, and reached the minimum at 24 h (1.20±0.08), and then increased. The glucose metabolism in group B was significantly lower than that in group D at each time point (F=7306.74, P<0.01), and significantly higher than that in group C ( F=471.50, P<0.01) . SUVmean within ROI had a significantly negative correla-tion with both ROI volume and NSS in group B at each time point( r values:-0.672 and -0.727, both P<0. 05) . Conclusions MicroPET/CT might visualize decreased glucose uptake of hematoma and peri-hema-toma brain tissue after cerebral hemorrhage. Curcumin might have a neuroprotective effect on ICH, and im-prove the glucose uptake in hematoma and peri-hematoma brain tissue.

Vasodilator stress MPI plays an important role in the detection of abnormal myocardial perfusion.Currently as the only selective A2A adenosine receptor agonist approved by FDA,the new myocardial stress agent regadenoson has been increasingly used in vasodilator stress MPI on clinic.This review describes the pharmacologic properties and overviews the clinical data on regadenoson,especially its diagnostic efficacy,prognosis predicting value and adverse effect as a vasodilator stress agent.